These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 14633695
1. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Sekharam M, Zhao H, Sun M, Fang Q, Zhang Q, Yuan Z, Dan HC, Boulware D, Cheng JQ, Coppola D. Cancer Res; 2003 Nov 15; 63(22):7708-16. PubMed ID: 14633695 [Abstract] [Full Text] [Related]
2. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro. Sekharam M, Nasir A, Kaiser HE, Coppola D. Anticancer Res; 2003 Nov 15; 23(2B):1517-24. PubMed ID: 12820418 [Abstract] [Full Text] [Related]
3. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Guerrero S, Casanova I, Farré L, Mazo A, Capellà G, Mangues R. Cancer Res; 2000 Dec 01; 60(23):6750-6. PubMed ID: 11118062 [Abstract] [Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E. Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546 [Abstract] [Full Text] [Related]
5. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD, Rudin CM. Oncogene; 2003 Feb 06; 22(5):688-98. PubMed ID: 12569361 [Abstract] [Full Text] [Related]
6. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein. Bhonde MR, Hanski ML, Magrini R, Moorthy D, Müller A, Sausville EA, Kohno K, Wiegand P, Daniel PT, Zeitz M, Hanski C. Oncogene; 2005 Jan 06; 24(1):148-56. PubMed ID: 15467762 [Abstract] [Full Text] [Related]
7. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M. Cancer Res; 2003 Oct 15; 63(20):6726-34. PubMed ID: 14583467 [Abstract] [Full Text] [Related]
8. Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells. Wen B, Deutsch E, Marangoni E, Frascona V, Maggiorella L, Abdulkarim B, Chavaudra N, Bourhis J. Br J Cancer; 2001 Dec 14; 85(12):2017-21. PubMed ID: 11747348 [Abstract] [Full Text] [Related]
9. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM. J Natl Cancer Inst; 2008 Jan 16; 100(2):109-20. PubMed ID: 18182619 [Abstract] [Full Text] [Related]
10. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Ravid D, Maor S, Werner H, Liscovitch M. Oncogene; 2005 Feb 17; 24(8):1338-47. PubMed ID: 15592498 [Abstract] [Full Text] [Related]
11. Antiapoptotic activity is dispensable for insulin-like growth factor I receptor-mediated clonogenic radioresistance after gamma-irradiation. Tezuka M, Watanabe H, Nakamura S, Yu D, Aung W, Sasaki T, Shibuya H, Miura M. Clin Cancer Res; 2001 Oct 17; 7(10):3206-14. PubMed ID: 11595716 [Abstract] [Full Text] [Related]
12. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649 [Abstract] [Full Text] [Related]
13. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC, Imai K. Oncogene; 1997 Jun 19; 14(24):2971-7. PubMed ID: 9205104 [Abstract] [Full Text] [Related]
14. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Fernández Y, España L, Mañas S, Fabra A, Sierra A. Cell Death Differ; 2000 Apr 19; 7(4):350-9. PubMed ID: 10773819 [Abstract] [Full Text] [Related]
15. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Chinni SR, Sarkar FH. Clin Cancer Res; 2002 Apr 19; 8(4):1228-36. PubMed ID: 11948137 [Abstract] [Full Text] [Related]
16. Costimulation by CD137/4-1BB inhibits T cell apoptosis and induces Bcl-xL and c-FLIP(short) via phosphatidylinositol 3-kinase and AKT/protein kinase B. Stärck L, Scholz C, Dörken B, Daniel PT. Eur J Immunol; 2005 Apr 19; 35(4):1257-66. PubMed ID: 15761847 [Abstract] [Full Text] [Related]
17. Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer. Min Y, Adachi Y, Yamamoto H, Ito H, Itoh F, Lee CT, Nadaf S, Carbone DP, Imai K. Cancer Res; 2003 Oct 01; 63(19):6432-41. PubMed ID: 14559833 [Abstract] [Full Text] [Related]
18. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA, Hidalgo M. Clin Cancer Res; 2004 Dec 01; 10(23):8059-67. PubMed ID: 15585641 [Abstract] [Full Text] [Related]
19. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Rashmi R, Kumar S, Karunagaran D. Carcinogenesis; 2005 Apr 01; 26(4):713-23. PubMed ID: 15661804 [Abstract] [Full Text] [Related]
20. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Martin MJ, Melnyk N, Pollard M, Bowden M, Leong H, Podor TJ, Gleave M, Sorensen PH. Mol Cell Biol; 2006 Mar 01; 26(5):1754-69. PubMed ID: 16478996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]